Must Asset Management Inc. Biomarin Pharmaceutical Inc Transaction History

Must Asset Management Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$74.28 - $92.69 $503,544 - $628,345	-6,779 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$75.51 - $84.79 $326,807 - $366,971	-4,328 Reduced 38.97%	6,779 $566,000
Q4 2020 Feb 03, 2021	BUY	$72.61 - $90.2 $806,479 - $1 Million	11,107 New	11,107 $966,000

637

177M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.2B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Must Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on Must Asset Management Inc. with notifications on news.